DE:9PL Stock Latest News
Company AnnouncementsGENinCode narrows losses as it advances global rollout of genetic heart and ovarian cancer tests1M ago
Company AnnouncementsGENinCode sets date for interim results as genetic risk platform gains strategic momentum1M ago
Company AnnouncementsGENinCode to unveil interim results as genetic risk tools gain clinical traction1M ago
Company AnnouncementsGENinCode Pilot Backs Genetic Scoring for Coronary Risk in Primary Care2M ago
Company AnnouncementsGENinCode Shareholders Approve All Resolutions at Annual General Meeting4M ago
Company AnnouncementsGENinCode targets accelerated genetic testing scale-up as revenues rise and U.S. adoption grows4M agoCompany AnnouncementsGENinCode Resets Share Option Plan to Align Incentives With Current Valuation5M ago
Company AnnouncementsGENinCode wins shareholder backing for major share issue as directors join fundraising8M ago
Company AnnouncementsGENinCode Lifts Fundraise to £4.7m After Strong Investor Demand8M ago
Company AnnouncementsGENinCode Raises £4.1m Following Completion of WRAP Retail Offer9M ago
Company AnnouncementsGENinCode Raises £3.9m via Discounted Placing and Director-Backed Subscription9M ago
Company AnnouncementsGENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep Discount9M agoCompany AnnouncementsGENinCode Launches Discounted £3.5m Fundraise to Back US and European Expansion9M ago
Company AnnouncementsGENinCode Partners with Sohin Genetics to Distribute Heart Disease Risk Test in Mexico10M ago
Company AnnouncementsGENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion11M ago
Company AnnouncementsGENinCode’s CARDIO inCode-Score® Test Gains New York State Approval11M ago
Company AnnouncementsGENinCode’s CARDIO inCode-Score® Validated for Enhanced Heart Disease Risk Prediction1y ago
Company AnnouncementsGENinCode Reports Revenue Growth Amid Strategic Expansions and Challenges1y ago
Company AnnouncementsGENinCode and NHS Launch ROCA Surveillance Service for Ovarian Cancer1y agoCompany AnnouncementsGENinCode Plc Observes Unexpected Share Price Movement Amid Ongoing FDA Discussions1y ago